All charts and data below are with dividends reinvested. (Inflation adjustment is OFF !)
MRNA total return snapshot: MRNA returned +91.99% over the past year and +109.63% YTD, with dividends reinvested. Since Dec. 7, 2018, MRNA is up +232.37% in nominal total return, or +17.10%/yr, and is currently −87.24% below its total-return high on Aug. 9, 2021.
Data ending Fri Jul. 17, 2026
| Fri 2018-12-07💬 to Fri 2026-07-17 |
YTD
Return |
1 Year
Return |
||||
|---|---|---|---|---|---|---|
| MRNA × |
+109.63%
2026-07-17 |
+91.99%
2026-07-17 |
||||
| Moderna Inc NASDAQ Common Stock | ||||||
| Fri 2018-12-07💬 to Fri 2026-07-17 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| MRNA × |
+232.37%
+17.10%/yr |
+4.14%/yr
(R2=0.010) |
||||
| Moderna Inc NASDAQ Common Stock | ||||||
| Fri 2018-12-07💬 to Fri 2026-07-17 |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| MRNA × |
$10,000.00
2018-12-07 |
$33,236.56
2026-07-17 |
||||
| Moderna Inc NASDAQ Common Stock | ||||||
| Year | MRNA |
|---|---|
| 2026 (YTD) | +109.63% |
| 2025 | −29.08% |
| 2024 | −58.19% |
| 2023 | −44.63% |
| 2022 | −29.28% |
| 2021 | +143.11% |
| 2020 | +434.10% |
| 2019 | +28.09% |
| 2018 | −17.90% |
| Fri 2018-12-07💬 to Fri 2026-07-17 |
Current
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| MRNA × |
−87.24%
from 2021-08-09 peak |
−95.38%
2025-11-20 from 2021-08-09 peak |
||||
| Moderna Inc NASDAQ Common Stock | ||||||
| Period ending Fri 2026-07-17 |
1
Year |
2
Years |
3
Years |
5
Years |
10
Years |
|
|---|---|---|---|---|---|---|
| MRNA × | +91.99% |
−50.17% −29.41%/yr |
−49.58% −20.41%/yr |
−78.42% −26.41%/yr |
— | |
| Moderna Inc NASDAQ Common Stock | ||||||
